UC Berkeley researchers trained AI to detect hidden warning signs of sudden cardiac death in routine ECG tests, according to ...

The FDA cleared EchoNext, the first artificial intelligence tool to detect structural heart disease before symptoms present.

AI/ML Innovations Inc. is a technology company developing artificial intelligence and neural-network solutions for digital health. Its proprietary technology applies advanced signal processing and ...

At the April 2026 Heart Rhythm Society Annual Meeting in Chicago, panelists gathered to discuss a myriad of topics in the rapidly growing cardiovascular care space. Song Zuo, MD, a specialist at the ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI™ algorithm for cardiac amyloidosis (CA) ...

ARTIFICIAL intelligence (AI) was shown to predict cardiac arrest with striking accuracy using time series electrocardiography (ECG) data, offering a potential breakthrough in early cardiac risk ...

Objective To explore patients’ experiences and perspectives on using a direct-to-consumer smartwatch with single-lead electrocardiography (1L-ECG) for ambulatory rhythm diagnostics in primary care.

New services and strategic partnerships advance Going for ZERO vision TOKYO, Dec. 11, 2025 /PRNewswire/ -- OMRON Healthcare Co., Ltd. announced new initiatives to accelerate its global ...